GridAI Technologies (GRDX) Current Assets (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Current Assets came in at $2.6 million in Q4 2025, down 96.89% YoY from $83.5 million in Q4 2024, and down 97.04% on a QoQ basis from $87.7 million in Q3 2025.
GridAI Technologies (GRDX) Current Assets (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Current Assets data on file, last reported at $2.6 million in Q4 2025.
- Quarterly Current Assets fell 96.89% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 million (down 96.89% YoY) and the FY2025 annual result came in at $2.6 million, down 96.89% from the prior year.
- Current Assets slipped to $2.6 million in Q4 2025, from $87.7 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $87.7 million in Q3 2025 to a low of $1.8 million in Q2 2022.
- A 5-year average of $29.2 million and a median of $7.5 million in 2021 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets surged 3485.15% — and 2025, when it tumbled 96.89%.
- Tracing GRDX's Current Assets over 5 years: stood at $9.4 million in 2021, then tumbled by 63.79% to $3.4 million in 2022, then jumped by 45.23% to $5.0 million in 2023, then surged by 1584.32% to $83.5 million in 2024, then plunged by 96.89% to $2.6 million in 2025.
- The last three Current Assets figures came in at $2.6 million (Q4 2025), $87.7 million (Q3 2025), and $83.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - | 2.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.60 Mn |
| Sep 30, 2025 | 87.70 Mn |
| Jun 30, 2025 | 83.32 Mn |
| Mar 31, 2025 | 83.46 Mn |
| Dec 31, 2024 | 83.48 Mn |
| Sep 30, 2024 | 83.84 Mn |
| Jun 30, 2024 | 84.39 Mn |
| Mar 31, 2024 | 7.49 Mn |
| Dec 31, 2023 | 4.96 Mn |
| Sep 30, 2023 | 3.98 Mn |
| Jun 30, 2023 | 2.35 Mn |
| Mar 31, 2023 | 3.53 Mn |
| Dec 31, 2022 | 3.41 Mn |
| Sep 30, 2022 | 2.55 Mn |
| Jun 30, 2022 | 1.79 Mn |
| Mar 31, 2022 | 6.55 Mn |
| Dec 31, 2021 | 9.42 Mn |
| Sep 30, 2021 | 7.50 Mn |
| Jun 30, 2021 | 8.62 Mn |
| Mar 31, 2021 | 13.17 Mn |